Analysis of samples from patients with prostate cancer showed that IL-1α expression in malignant cells is associated with the increased progression of the disease, as well as in correlation with prostate specific antigen (PSA) levels in the serum [96]. This evidence concerns the gene KLK3 and prostate carcinoma.